NCT01580592View on ClinicalTrials.gov

Cold Urticaria Treatment With Xolair

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Cold Contact Urticaria
Interventions
DRUG

Omalizumab

150mg, s.c., every 4 weeks

DRUG

Omalizumab

300mg, s.c., every 4 weeks

DRUG

Placebo

Placebo, s.c., every 4 weeks

Trial Locations (3)

10117

Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin

Unknown

University Aachen, Aachen

Hautklinik Mainz, Mainz

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER